Evidence map›Paper›PMID 36532646›Full record

ArticleIranian journal of pathology2022

Crescentic Glomerulonephritis, A Rare Presentation of Alport Syndrome.

Tahereh Malakoutian, Fatemeh Nili, Sholeh Ghasemi Darbrood, Samaneh Salarvand, Mitra Mehrazma

Open access · goldAbstract readCase Reports
PubMed Full text at PMC Publisher
In one paragraph

Article in Iranian journal of pathology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact, top 81% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 0 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 1 country.

Tahereh MalakoutianDepartment of Nephrology, Shahid Hasheminejad Kidney Center, Iran University of Medical Sciences, Tehran, Iran.
Fatemeh NiliDepartment of Pathology, Imam Khomeini Hospital Complex, Tehran University of Medical Sciences, Tehran, Iran.
Sholeh Ghasemi DarbroodDepartment of Nephrology, Shahid Hasheminejad Kidney Center, Iran University of Medical Sciences, Tehran, Iran.
Samaneh SalarvandDepartment of Pathology, Imam Khomeini Hospital Complex, Tehran University of Medical Sciences, Tehran, Iran.
Mitra MehrazmaDepartment of Pathology, Shahid Hasheminejad Kidney Center, Iran University of Medical Sciences, Tehran, Iran.
Imam Khomeini Hospital · IRIran University of Medical Sciences · IRHasheminejad Kidney Center · IR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Crescentic glomerulonephritis (GN) is a feature of severe glomerular injury. Anti-GBM disease, immune-complex mediated glomerulonephritis, and ANCA-associated vasculitis are the main causes of crescentic GN. Alport syndrome is a progressive form of hereditary nephritis presenting with hematuria and progression to proteinuria and renal failure. Herein we present a 16-year-old male with rapidly progressive glomerulonephritis syndrome, sensory-neural hearing loss, and a family history of hematuria and proteinuria in his mother and aunt. Light microscopic examination shows cellular crescent in glomeruli. In an electron microscopy study, GBM changes compatible with Alport syndrome were identified. Alport syndrome rarely can be presented as crescentic GN. Electron microscopy is necessary for the diagnosis of this type of pauci-immune crescentic glomerulonephritis.

Indexed as

AlportCrescentic glomerulonephritisHereditary nephritis

Identifiers

PMID36532646
PMCPMC9745756
OpenAlexW4308427900

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.